202 related articles for article (PubMed ID: 9418644)
1. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat.
Cole BJ; Bostrom MP; Pritchard TL; Sumner DR; Tomin E; Lane JM; Weiland AJ
Clin Orthop Relat Res; 1997 Dec; (345):219-28. PubMed ID: 9418644
[TBL] [Abstract][Full Text] [Related]
2. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model.
Hall J; Sorensen RG; Wozney JM; Wikesjö UM
J Clin Periodontol; 2007 May; 34(5):444-51. PubMed ID: 17448048
[TBL] [Abstract][Full Text] [Related]
3. Ectopic bone formation using osteogenic protein-1 carried by a solution precipitated hydroxyapatite.
Zhang R; Xu D; Landeryou T; Toth C; Dimaano N; Berry J; Evans J; Hawkins M
J Biomed Mater Res A; 2004 Dec; 71(3):412-8. PubMed ID: 15472924
[TBL] [Abstract][Full Text] [Related]
4. Growth of new bone guided by implants in a murine calvarial model.
Freilich M; M Patel C; Wei M; Shafer D; Schleier P; Hortschansky P; Kompali R; Kuhn L
Bone; 2008 Oct; 43(4):781-8. PubMed ID: 18589010
[TBL] [Abstract][Full Text] [Related]
5. Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate.
Vehof JW; Mahmood J; Takita H; van't Hof MA; Kuboki Y; Spauwen PH; Jansen JA
Plast Reconstr Surg; 2001 Aug; 108(2):434-43. PubMed ID: 11496187
[TBL] [Abstract][Full Text] [Related]
6. Self-regenerating bone implant: ectopic osteoinduction following intramuscular implantation of a combination of rhBMP-2, atelopeptide type I collagen and porous hydroxyapatite.
Kusumoto K; Bessho K; Fujimura K; Konishi Y; Ogawa Y; Iizuka T
J Craniomaxillofac Surg; 1996 Dec; 24(6):360-5. PubMed ID: 9032604
[TBL] [Abstract][Full Text] [Related]
7. [Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): an animal study performed at the metaphyseal bone bed in dogs].
Hartwig CH; Esenwein SA; Pfund A; Küsswetter Dagger W; Herr G
Z Orthop Ihre Grenzgeb; 2003; 141(6):705-11. PubMed ID: 14679438
[TBL] [Abstract][Full Text] [Related]
8. Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2.
Gruber R; Weich HA; Dullin C; Schliephake H
Clin Oral Implants Res; 2009 Jan; 20(1):24-30. PubMed ID: 19126104
[TBL] [Abstract][Full Text] [Related]
9. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
[TBL] [Abstract][Full Text] [Related]
10. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
11. Heterotopic bone formation around sintered porous-surfaced Ti-6Al-4V implants coated with native bone morphogenetic proteins.
Simon Z; Deporter DA; Pilliar RM; Clokie CM
Implant Dent; 2006 Sep; 15(3):265-74. PubMed ID: 16966900
[TBL] [Abstract][Full Text] [Related]
12. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites.
Okubo Y; Bessho K; Fujimura K; Konishi Y; Kusumoto K; Ogawa Y; Iizuka T
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):62-6. PubMed ID: 10691147
[TBL] [Abstract][Full Text] [Related]
13. Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle.
Wildemann B; Kandziora F; Krummrey G; Palasdies N; Haas NP; Raschke M; Schmidmaier G
J Control Release; 2004 Mar; 95(2):249-56. PubMed ID: 14980773
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2.
Kakudo N; Kusumoto K; Wang YB; Iguchi Y; Ogawa Y
Life Sci; 2006 Oct; 79(19):1847-55. PubMed ID: 16857215
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ectopic osteoinduction in vivo by recombinant human BMP-2 and recombinant Xenopus BMP-4/7 heterodimer.
Kusumoto K; Bessho K; Fujimura K; Akioka J; Ogawa Y; Iizuka T
Biochem Biophys Res Commun; 1997 Oct; 239(2):575-9. PubMed ID: 9344873
[TBL] [Abstract][Full Text] [Related]
16. Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study.
Yoo D; Tovar N; Jimbo R; Marin C; Anchieta RB; Machado LS; Montclare J; Guastaldi FP; Janal MN; Coelho PG
J Biomed Mater Res A; 2014 Jun; 102(6):1921-7. PubMed ID: 23853058
[TBL] [Abstract][Full Text] [Related]
17. Histological characterization of the early stages of bone morphogenetic protein-induced osteogenesis.
Vehof JW; Takita H; Kuboki Y; Spauwen PH; Jansen JA
J Biomed Mater Res; 2002 Sep; 61(3):440-9. PubMed ID: 12115469
[TBL] [Abstract][Full Text] [Related]
18. Ectopic bone formation by composites of BMP and metal implants in rats.
Herr G; Hartwig CH; Boll C; Küsswetter W
Acta Orthop Scand; 1996 Dec; 67(6):606-10. PubMed ID: 9065076
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
Lee J; Decker JF; Polimeni G; Cortella CA; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
J Clin Periodontol; 2010 Jun; 37(6):582-90. PubMed ID: 20345393
[TBL] [Abstract][Full Text] [Related]
20. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
